
- Telehealth Visits
- Insurance plan information


Phuong Hoang, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information




Phuong Hoang, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Psychiatry/Neurology-Neurology
Residency
- Neurology, Stanford University Hospitals & Clinics GME
Internship
- Internal Medicine, Stanford University Hospitals & Clinics GME
Degree
- MDD, Columbia University, Vagelos College of Physicians & Surgeons
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224227%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224227%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 40 reviews
- December 23, 20255 out of 5 Stars
Dr Hoang was very listened to me and made some changes to meds to help me
- December 16, 20255 out of 5 Stars
Knowledgeable, excellent communication. Confident in my plan of care.
- December 10, 20254.9 out of 5 Stars
This is the place to go!
- December 3, 20255 out of 5 Stars
Dr. Hoang is excellent. She has given me and my family 5 star service from day one of working with her! I would highly recommend her to any of my family and friends.
- November 28, 20255 out of 5 Stars
Dr Hoang was very professional and made excellent recommendations on the planned treatment. She had carefully read my history and proposed a sensible, reasoned approach. I liked her very much. She was very skillful with the injections and I felt almost no pain. An excellent experience.
- November 26, 20255 out of 5 Stars
Great doc
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.